Ivan M.
- Country
- Bulgaria
- Department
- Department of cardiology
Research Overview
- Efficacy and Safety Evaluation of Subcutaneous Selatogrel in Preventing Recurrent Acute Myocardial Infarction in Post-AMI Patients
- Phase 3 Double-Blind, Placebo-Controlled Study on the Efficacy and Safety of Plozasiran in Adults with Hypertriglyceridemia
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Plozasiran in Adults with Severe Hypertriglyceridemia
Data & Insights
Has run more than one trial at 494 of 1085 partner sites.
Specializations
Cardiovascular Research
The investigator specializes in treating acute coronary syndrome and conducting research on cardiovascular event prevention in post-heart attack patients. Their work focuses on exploring innovative therapeutic approaches for reducing major adverse cardiovascular events.
- Post-myocardial infarction care
- Cardiovascular event prevention
- Acute coronary care management
Metabolic Disorders
The investigator conducts research in the field of lipid metabolism disorders, with particular emphasis on treating various forms of hypertriglyceridemia. Their work encompasses both severe and moderate cases of elevated triglyceride levels.
- Severe hypertriglyceridemia treatment
- Lipid level management
- Metabolic disorder therapeutics
Cardiac Electrophysiology
The investigator focuses on treating patients with atrial fibrillation, particularly those who cannot receive conventional oral anticoagulation therapy. Their research explores alternative therapeutic approaches for stroke prevention in this high-risk population.
- Atrial fibrillation management
- Stroke prevention strategies
- Alternative anticoagulation approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.